C Ray Therapeutics Secures Key Radiopharmaceutical License
CHENGDU, China, June 2026 C Ray Therapeutics (Chengdu) Co., Ltd. announced that it has officially obtained a Radiopharmaceutical Manufacturing...
cGMP
Advertisement
Andelyn Biosciences Earns ICMC Gene Therapy Certification
COLUMBUS, Ohio, May 13, 2026 Andelyn Biosciences announced that it has received full certification under the Initiative for Certification...
Samsung Biologics Acquires GSK U.S. Manufacturing Site
INCHEON, South Korea & ROCKVILLE, Maryland, USA — March 31, 2026 Samsung Biologics has officially completed the acquisition of...
Cardinal Health Expands Ac-225 Supply for Cancer Therapies
Dublin, Ohio, USA – April 1, 2026 In a significant advancement for the rapidly evolving field of targeted cancer...
FDA Expands Regulatory Flexibility for Cell and Gene Therapies
White Oak, Maryland – January 2026 — The U.S. Food and Drug Administration has announced a more flexible regulatory...
Advertisements
Valneva, Serum Institute End Chikungunya Vaccine License
SAINT-HERBLAIN, FRANCE | December 31, 2025 — Valneva and Serum Institute of India announced the discontinuation of their license...
Gallant Reaches FDA Safety Milestone for First Stem Cell Therapy in Cats
Dateline Introduction – San Diego, November 10, 2025:Gallant, an animal health biotechnology leader, has achieved a pivotal regulatory milestone...
Piramal Pharma Reports Q2 & H1 FY26 Results, Strengthens Global CDMO and Generics Capabilities
Dateline – Mumbai, India, November 5, 2025:Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a leading global pharmaceutical, health and...
Wave Life Sciences Advances RNA Innovation Ahead of Q3 2025 Results
CAMBRIDGE, Mass., November 4, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company pioneering the use...
Advertisement
